Singapore OncoGenome Laboratory

Singapore OncoGenome Laboratory (SOGL) is a specialized molecular diagnostics company that focuses on precision oncology and personalized medicine. Acquired by the SGX-listed Clearbridge Health in 2017, SOGL provides advanced genomic testing services, including next-generation sequencing (NGS) and liquid biopsy solutions, to clinical practitioners and patients across Asia. The laboratory is licensed to perform a variety of high-complexity tests that identify actionable genetic mutations and monitor therapy response through non-invasive techniques. By integrating genomic data with clinical insights, SOGL supports oncologists in tailoring treatment plans for various cancer types, particularly lung, breast, and colorectal cancers. The company operates as a key component of Clearbridge Health’s medical laboratory services division.